Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07351656 · ClinicalTrials.gov registry record · NA
A Study Of Heart Disease Using AI-Enabled Electrocardiography And Focused Cardiac Ultrasound
A NA study, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 19,300
- Enrollment target
NCT07351656: Recruiting NA study, sponsored by Mayo Clinic.
NCT07351656 is a NA study that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 19,300 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1276% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07351656, a NA study, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 19,300 participants
- Enrollment target
Study Summary
A study to evaluate feasibility, diagnostic yield, accuracy, and actionable thresholds of POC, immediate-feedback AI-ECG + AI FoCUS screening for cardiac disease in well described community populations.
Primary Outcome
The percentage will be calculated as the number of participants whose AI-ECG results indicate a positive finding and are subsequently confirmed by echocardiography, divided by the total number of participants assessed, multiplied by 100.
Interventions
- DIAGNOSTIC_TEST Focused Cardiac Ultrasound
- DIAGNOSTIC_TEST 6-Lead AI-ECG
- DIAGNOSTIC_TEST 12-Lead AI-ECG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19,300 participants |
| Start Date | 2026-03-09 |
| Est. Completion | 2028-02 |
| Phase | NA |
What NCT07351656 shows while recruiting
NCT07351656 is an interventional study that assigns participants to a tested intervention. Its 19,300 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1276% higher).
The record links to 0 conditions, and to 3 interventions - of which Focused Cardiac Ultrasound is the first listed.
NCT07351656 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07351656 about?
NCT07351656 is a clinical study titled "A Study Of Heart Disease Using AI-Enabled Electrocardiography And Focused Cardiac Ultrasound". A study to evaluate feasibility, diagnostic yield, accuracy, and actionable thresholds of POC, immediate-feedback AI-ECG + AI FoCUS screening for cardiac disease in well described community populations.
What is the current status of trial NCT07351656?
This trial is currently recruiting. It is a NA study. The enrollment target is 19,300 participants. The study started on 2026-03-09. Estimated completion is 2028-02.
What interventions are being tested in trial NCT07351656?
The interventions under investigation include: Focused Cardiac Ultrasound (DIAGNOSTIC_TEST), 6-Lead AI-ECG (DIAGNOSTIC_TEST), 12-Lead AI-ECG (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07351656?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07351656's enrollment target sits among peer trials
19,300 11th of 2000 higher than 1,990 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05555095 · 19,331 participants
Examining Digital Health Care Delivery Models Through Medicaid Collaborative
- NCT07152249 · 19,480 participants · NA
Advancing Strategies to Optimize the PerIopeRativE Management of PostOperative Nausea and Vomiting (ASPIRE-PONV) Trial
- NCT00271180 · 20,000 participants
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- NCT00830557 · 20,000 participants
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI